CNTN (Canton Strategic Holdings) Other Stockholders Equity: $0.00 Mil (As of Mar. 2026)


CNTN Canton Strategic Holdings Inc CNTN
30 GF Score
Price $2.29
! 2 Warning Signs
View Full Analysis

What is Canton Strategic Holdings Other Stockholders Equity?

Canton Strategic Holdings CNTN -1.72% 30 Other Stockholders Equity is $0.00 Mil as of Mar. 2026. GuruFocus rates CNTN with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Canton Strategic Holdings's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $0.00 Mil.

Canton Strategic Holdings's quarterly Other Stockholders Equity declined from Sep. 2025 ($-0.00 Mil) to Dec. 2025 ($-0.00 Mil) but then increased from Dec. 2025 ($-0.00 Mil) to Mar. 2026 ($0.00 Mil).

Canton Strategic Holdings's annual Other Stockholders Equity stayed the same from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then declined from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($-0.00 Mil).


Canton Strategic Holdings Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Canton Strategic Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Canton Strategic Holdings Other Stockholders Equity Chart

Canton Strategic Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial -0.00 -0.00 0.00 0.00 -0.00

Canton Strategic Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 -0.00 -0.00 0.00
CNTN
30GF Score
Canton Strategic Holdings Inc CNTN
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Canton Strategic Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Canton Strategic Holdings (CNTN) has a Other Stockholders Equity of $0.00 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Canton Strategic Holdings and its competitors.
Is Canton Strategic Holdings' Other Stockholders Equity too high?
Canton Strategic Holdings' current Other Stockholders Equity is $0.00 Mil. Overall, Canton Strategic Holdings has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Canton Strategic Holdings' Other Stockholders Equity compare to RNA and TARA?
Canton Strategic Holdings' Other Stockholders Equity of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Canton Strategic Holdings and its competitors. Canton Strategic Holdings's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canton Strategic Holdings stock overvalued right now?
Canton Strategic Holdings (CNTN) has a current Other Stockholders Equity of $0.00 Mil. The current Other Stockholders Equity is $0.00 Mil. Canton Strategic Holdings' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Canton Strategic Holdings (CNTN), the current Other Stockholders Equity is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Canton Strategic Holdings Business Description

Address 34 Shrewsbury Avenue, Suite 1C, Red Bank, NJ, USA, 07701
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
30GF Score

Get the complete analysis for CNTN

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.29
Price